FAMILIAL HYPERCHOLESTEREMIA: WHEN STATINS, EZETIMIBE & PCSK9 INHIBITORS ARE NOT ENOUGH
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)32980-2
Abstract: Patients with familial hypercholesteremia (FH) require lipoprotein aphaeresis (LA), mipomersen or lomitapide to control their LDL-C. Proprotein convertase subtisilin kexin type 9 (PCSK9) inhibitors have reduced the use of these treatment strategies but some FH… read more here.
Keywords: statins ezetimibe; pcsk9 inhibitors; hypercholesteremia statins; ezetimibe pcsk9 ... See more keywords